- Joined
- Nov 2, 2006
- Messages
- 1,047
http://www.blackwell-synergy.com/ac...(158+KB)&doi=10.1111/j.1365-2036.2007.03536.x
Results
Azathioprine, infliximab and adalimumab are effective at maintaining
remission in Crohn’s disease. Natalizumab is also effective, but there are
concerns about its potential association with progressive multifocal leukoencephalopathy.
Long-term enteral nutritional supplementation,
enteric-coated omega-3 fatty acids and intramuscular methotrexate may
also be effective but the evidence for these is based on relatively small
studies. The available evidence does not support the use of oral 5-
aminosalicylates agents, corticosteroids, anti-mycobacterial agents, probiotics
or ciclosporin as maintenance therapy in Crohn’s disease.
So I wonder why most of us are put on long term 5 ASA treatment (I have been taking it for almost 8 years now!!!)
Results
Azathioprine, infliximab and adalimumab are effective at maintaining
remission in Crohn’s disease. Natalizumab is also effective, but there are
concerns about its potential association with progressive multifocal leukoencephalopathy.
Long-term enteral nutritional supplementation,
enteric-coated omega-3 fatty acids and intramuscular methotrexate may
also be effective but the evidence for these is based on relatively small
studies. The available evidence does not support the use of oral 5-
aminosalicylates agents, corticosteroids, anti-mycobacterial agents, probiotics
or ciclosporin as maintenance therapy in Crohn’s disease.
So I wonder why most of us are put on long term 5 ASA treatment (I have been taking it for almost 8 years now!!!)